RESEARCH-USE BIOSIMILAR ANTIBODY
Geptanolimab
Monoclonal antibody · IgG4
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-519
CATALOG NUMBERSC-BS-519
MOLECULAR WEIGHTApprox. 144.14 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.
Geptanolimab is a recombinant research-use antibody directed against PDCD1.